Healthcare

19:19

                            Eli Lilly CEO: Conduct research on Alzheimer's disease prevention and other brain diseases
                        
                            Eli Lilly's CEO said that research on Alzheimer's disease prevention and other brain diseases will be carried out.
                        
19:16

                            Eli Lilly CEO: It's important that we don't raise drug prices.
                        
                            Eli Lilly's CEO said it's important that they don't raise drug prices.
                        
16:14

                            Morgan Stanley: Orforglipron, an oral weight loss drug, has become a driving force for stock prices, and Eli Lilly can still rise by another 34%
                        
                            Morgan Stanley said that the oral weight loss drug Orforglipron has become a driving force for the stock price, and Eli Lilly can still rise by another 34%.
                        
09:27

                            Most of the A-share weight loss drug sectors opened higher, with Kingchem Biosciences rising more than 10%, Huadong Medicine rising more than 4%, and Hanyu Pharmaceutical and Baihua Pharmaceutical following suit.
                        
09:27

                            Diet drug concept stocks were active at the beginning of trading, and Jinkai Biosciences rose by more than 10%
                        
                            Weight loss drug concept was active at the beginning of the session, with Jinkai Biosciences rising more than 10%, followed by Haofan Bio, Huadong Medicine, Hanyu Pharmaceutical, Baihua Pharmaceutical, Yipinhong, Changshan Pharmaceutical, etc. On the news front, Eli Lilly's oral weight loss drug Orforglipron had impressive Phase III clinical data, and its stock price rose by more than 14%.
                        
21:38

                            Novo Nordisk fell 8% in early trading
                        
                            Novo Nordisk fell 8% in early trading after its weight loss drug competitor Eli Lilly achieved positive results in a Phase 3 trial of an oral weight loss drug.
                        
21:30

                            U.S. stocks open: three major indexes rise and fall, Dow opens more than 1% lower
                        
                            At the opening of the US stock market, the Dow Jones Industrial Average fell 1.23%, the S&P 500 rose 0.35%, and the Nasdaq rose 0.53%. TSMC rose more than 2%, and its Q1 net profit increased by 60% year-on-year, exceeding expectations. Eli Lilly rose 14%. The company released data on its weight loss drug study, and participants lost an average of 16 pounds at the highest dose. UnitedHealth fell 17% as the company lowered its annual profit forecast.
                        
19:25

                            BMO: Lowered Pfizer (PFE.N) price target to $30 from $36.
                        
18:55

                            Eli Lilly (LLY.N) surged 13% in premarket trading after it released data on a study of its weight-loss drug.
                        
18:54

                            Eli Lilly's US stock surged 13% before the market opened
                        
                            Eli Lilly's U.S. shares surged 13% in premarket trading after it released data on a study of its weight-loss drug.
                        
17:19

                            Information from the Hong Kong Stock Exchange shows that UBS Group's holdings in WuXi AppTec's (02359.HK) H shares have fallen from 7.39% on April 11 to 6.72%.
                        
17:13

                            UBS increases stake in WuXi AppTec H shares
                        
                            Data from the Hong Kong Stock Exchange showed that UBS Group increased its long position in WuXi AppTec's H shares from 6.73% to 7.30% on April 10.
                        
11:13

                            Hong Kong-listed pharmaceutical stocks continued to weaken, with Ascletis Pharma (01672.HK) falling more than 12%, WuXi Biologics (02269.HK) falling more than 5%, Zai Lab (09688.HK), Zhaoyan Pharmaceutical (06127.HK) and others following suit.
                        
15:34

                            The Hong Kong stock market's biopharmaceutical sector continued to weaken, with Tiger Pharmaceuticals (03347.HK) falling more than 4%, BeiGene (06160.HK) falling more than 2%, and WuXi AppTec (02359.HK) and others following suit.
                        
00:16

                            The three major U.S. stock indices fell, the Nasdaq turned to decline, and Pfizer (PFE.N) once gave up its gains.
                        
1744975163
113929
3

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Trends

AI AI Tesla bitcoin Xiaomi Alibaba Nvidia Tencent Huawei Apple

Weekly Highlights

                                    Nvidia (NVDA.O): Blackwell chips have begun production at TSMC's chip factory in Phoenix, Arizona.
                            2025-04-14

                                    Li Lecheng, Secretary of the Party Leadership Group of the Ministry of Industry and Information Technology, meets with Sultan, Minister of Industry and Advanced Technology of the United Arab Emirates
                            2025-04-18

                                    According to ABC News: The helicopter carrying the CEO of Siemens, his wife and young children crashed into the Hudson River in New York City.
                            2025-04-11

                                    BOE A: Net profit is expected to increase by 63% to 68% year-on-year in the first quarter of 2025
                            2025-04-15

                                    China Great Wall Information, a subsidiary of China Great Wall, won the bid for the AI acceleration server project of Heilongjiang Rural Credit Cooperatives
                            2025-04-11